+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Endoscopes Market by Product Type, Application, End User, Technology, Usage Mode - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337434
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The endoscopes market is undergoing rapid transformation as evolving technologies, regulatory standards, and operational demands drive both product innovation and procurement strategy for healthcare providers worldwide. This report gives senior executives an actionable overview of the sector’s core dynamics, competitive environment, and strategic outlook.

Market Snapshot: Endoscopes Market Growth and Outlook

The Endoscopes Market grew from USD 14.33 billion in 2024 to USD 15.15 billion in 2025. It is expected to continue growing at a CAGR of 5.56%, reaching USD 19.84 billion by 2030. Market momentum is shaped by increasing demand for minimally invasive procedures, enhanced imaging technologies, and growing adoption of single-use platforms. Evolving regulatory frameworks and shifting reimbursement environments are influencing both regional growth patterns and innovation priorities as decision-makers respond to new efficiency pressures and supply chain realities.

Scope & Segmentation of the Endoscopes Market

Executive leaders gain broad visibility into the market by examining product diversity, applications, technology trends, and regional activity. This research categorizes the endoscopes sector as follows:

  • Product Types: Capsule endoscopes, flexible endoscopes (including arthroscopes by knee and shoulder, bronchoscopes, gastrointestinal types like colonoscopes, enteroscopes, gastroscopes, and urological models), rigid instruments (hysteroscopes, laparoscopes, otoscopes, proctoscopes), and single-use variants for bronchoscopy, cystoscopy, and GI procedures.
  • Applications: Arthroscopy, gastrointestinal diagnostics and therapies (with distinct lower and upper GI focus), gynecological (notably hysteroscopy), laparoscopy, pulmonary procedures (diagnostic and therapeutic), and urological interventions (cystoscopy, ureteroscopy).
  • End Users: Ambulatory surgical centers (with leading use in GI and orthopedics), diagnostic centers, hospitals (community and tertiary), and specialty clinics integrating advanced imaging with care delivery.
  • Technologies: Digital endoscopes (high-definition and 4K), fiber optic systems, video platforms (standard, HD, ultra-HD), and wireless capsule devices supporting remote diagnostics and data acquisition.
  • Usage Modes: Reusable platforms (both limited-use and multi-procedure) and single-use devices designed for general or procedure-specific applications.
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (from Western Europe to Gulf states and Africa), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia, and other key economies).
  • Key Companies: Market leaders and disruptors include Olympus Corporation, FUJIFILM Holdings, HOYA Corporation, Karl Storz, Stryker, Boston Scientific, Medtronic, Cook Medical, Richard Wolf, and CONMED Corporation.

Key Takeaways for Decision-Makers

  • Demand for minimally invasive endoscopic techniques is rising, leading providers to invest in advanced digital and single-use systems with enhanced workflow integration.
  • Technological convergence favors platforms combining high-definition imaging, real-time analytics, and AI-supported diagnostics for improved procedural consistency and patient outcomes.
  • Geopolitical uncertainties and evolving trade policies require organizations to diversify supplier networks and explore alternative manufacturing hubs, strengthening operational resilience for the endoscopes market.
  • Shifts in reimbursement, particularly those rewarding procedural efficacy and infection control, are prompting greater adoption of disposable endoscope technologies and analytics-enabled platforms.
  • Strategic partnerships between device makers, technology startups, and healthcare institutions are accelerating new product introductions and supporting regional adoption efforts.
  • Environmental and regulatory pressures are influencing design choices, with sustainability and traceability becoming part of procurement criteria, especially in large health systems and public tenders.

Tariff Impact: Strategic Supply Chain Adjustments

Recent US tariffs on imported endoscope components and devices have affected cost structures for OEMs sourcing optics and precision parts from overseas. Manufacturers have responded by revisiting supplier contracts, shifting production to new regions, and facing increased transition costs and longer lead times for new launches. This shift is prompting service providers and ambulatory centers to adapt by consolidating purchasing and seeking domestic supply partnerships. The changing tariff environment is also encouraging organizations to build more redundancy and flexibility into their sourcing strategies, reinforcing the importance of procurement agility in a volatile trade context.

Methodology & Data Sources

This market analysis is grounded in primary interviews with clinical specialists, procurement leads, and device engineers, along with anonymized surveys capturing facility-level usage and purchasing behavior. Secondary research incorporates peer-reviewed publications, regulatory documentation, and proprietary patent databases, with rigorous cross-validation to provide balanced, actionable insights.

Why This Report Matters

  • Executives and procurement leaders gain a clear view of product, application, and technology trends informing investment priorities and supplier selection in the endoscopes sector.
  • Regional and segment-level analysis equips decision-makers to benchmark operations, mitigate compliance risks, and anticipate evolving customer needs in diverse healthcare markets.
  • Actionable insights support strategic planning for new technology adoption, risk management, and sustainability objectives aligned to organizational growth strategies.

Conclusion

The endoscopes market is evolving quickly, shaped by technology, regulatory shifts, and changing clinical priorities. Senior stakeholders who align organizational strategy with these trends can achieve greater competitiveness and operational resilience in a dynamic healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Endoscopes Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of chronic diseases and gastrointestinal disorders
5.1.1.2. Rising patients preferences for minimally invasive procedures
5.1.1.3. High adoption of disposable endoscopes due to growing cross-contamination issues with reusable endoscopes
5.1.2. Restraints
5.1.2.1. High cost of endoscopes with increasing product recalls
5.1.3. Opportunities
5.1.3.1. Advancements and ongoing developments in endoscopes
5.1.3.2. Increasing potential of robot-assisted endoscopes
5.1.4. Challenges
5.1.4.1. Complications associated with endoscopy procedures
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Endoscopes Market, by Product
6.1. Introduction
6.2. Capsule Endoscopes
6.3. Disposable Endoscopes
6.4. Flexible Endoscopes
6.5.1. Bronchoscopes
6.5.2. Colonoscopes
6.5.3. Duodenoscopes
6.5.4. Laryngoscopes
6.5.5. Nasopharyngoscopes
6.5.6. Pharyngoscopes
6.5.7. Rhinoscopes
6.5.8. Sigmoidoscopes
6.5.9. Upper Gastrointestinal Endoscopes
6.5. Rigid Endoscopes
6.6.1. Arthroscopes
6.6.2. Cystoscopes
6.6.3. Gynecology Endoscopes
6.6.4. Laparoscopes
6.6.5. Neuroendoscopes
6.6.6. Urology Endoscopes
6.6. Robot Assisted Endoscopes
7. Endoscopes Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgery Centers
7.3. Diagnostic Centers
7.4. Hospitals
8. Americas Endoscopes Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Endoscopes Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Endoscopes Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
11.3.1. Merger & Acquisition
11.3.1.1. Boston Scientific closes acquisition of Apollo Endosurgery
11.3.1.2. Bain acquires Olympus life sciences unit for $3.1B
11.3.2. Agreement, Collaboration, & Partnership
11.3.2.1. Cook Medical to supply endoscopy devices to Vizient
11.3.2.2. Scivita, Boston Scientific partner for single-use Percutaneous Choledochoscope
11.3.3. New Product Launch & Enhancement
11.3.3.1. Fujifilm expands endoscopy solutions for gastrointestinal applications
11.3.3.2. Integrated Endoscopy announces the global launch of Gen II NUVIS Single-Use, 4K, battery operated cordless arthroscope
11.3.4. Investment & Funding
11.3.4.1. EvoEndo announces investment from AGA’s GI opportunity fund
11.3.4.2. IQ Endoscopes secures £5.2m investment
11.3.5. Award, Recognition, & Expansion
11.3.5.1. Biomerics completes Athens facility expansion in the US
11.3.5.2. Ethicon’s MONARCH Endoscopic Robotic Platform receives FDA 510(k) clearance for urology procedures
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. 3NT Medical, Inc.
12.1.2. Altek Corporation
12.1.3. Ambu A/S
12.1.4. Ambu Inc.
12.1.5. AMNOTEC International Medical GmbH
12.1.6. B. Braun Melsungen AG
12.1.7. Becton, Dickinson and Company
12.1.8. BioVision Technologies, LLC by ATL Technology, LLC
12.1.9. Boston Scientific Corporation
12.1.10. Carl Zeiss AG
12.1.11. ConMed Corporation
12.1.12. Cook Medical Incorporated
12.1.13. EndoMed Systems GmbH.
12.1.14. enlightenVue, Inc.
12.1.15. Fujifilm Holdings Corporation
12.1.16. Hill-Rom Holdings, Inc.
12.1.17. Integrated Endoscopy
12.1.18. Intersurgical Ltd.
12.1.19. J-Sol Medical Co., Ltd.
12.1.20. Johnson & Johnson Services, Inc.
12.1.21. Medtronic PLC
12.1.22. NeoScope, Inc.
12.1.23. OBP Medical Corporation
12.1.24. Olympus Corporation
12.1.25. OTU Medical Inc.
12.1.26. Parburch Medical Developments Ltd
12.1.27. PENTAX Medical
12.1.28. Smith & Nephew plc
12.1.29. STERIS Corporation
12.1.30. Stryker Corporation
12.1.31. Teleflex Incorporated
12.1.32. The Cooper Companies, Inc.
12.1.33. The Surgical Company
12.1.34. Zsquare Ltd.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. ENDOSCOPES MARKET RESEARCH PROCESS
FIGURE 2. ENDOSCOPES MARKET SIZE, 2023 VS 2030
FIGURE 3. ENDOSCOPES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ENDOSCOPES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ENDOSCOPES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENDOSCOPES MARKET DYNAMICS
FIGURE 7. ENDOSCOPES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ENDOSCOPES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ENDOSCOPES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. ENDOSCOPES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ENDOSCOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ENDOSCOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ENDOSCOPES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ENDOSCOPES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ENDOSCOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ENDOSCOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ENDOSCOPES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. ENDOSCOPES MARKET SHARE, BY KEY PLAYER, 2023

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Endoscopes market report include:
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • Karl Storz SE & Co. KG
  • Stryker Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Cook Medical LLC
  • Richard Wolf GmbH
  • CONMED Corporation

Table Information